Koss-Olinger Consulting’s Intellia Therapeutics NTLA Stock Holding History

Koss-Olinger Consulting’s Portfolio NTLA Stock Details NTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$94K	Hold
2025 Q2	$93.8K	Buy
2021 Q3	–	Sell
2021 Q2	$1.29M	Hold
2021 Q1	$642K	Buy